XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
OPERATING ACTIVITIES:    
Net income $ 6,232 $ 13,168
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 27,443 22,005
Stock based compensation 2,260 1,665
Amortization of deferred commissions 6,900 6,555
Provision for doubtful accounts 99 160
Deferred income taxes 2,066 2,330
Loss on non-marketable equity investments 258 8
Non-cash paid time off expense (1,011) 0
Non-cash royalty expense 0 (3,440)
Change in fair value of non-marketable equity investments 0 (1,181)
Other 132 321
Changes in operating assets and liabilities:    
Accounts and unbilled receivables (13,907) 9
Prepaid royalties (162) 1,394
Other prepaid expenses and other current assets 1,335 972
Deferred commissions (9,854) (6,693)
Other assets (278) 308
Accounts payable and accrued expenses (3,062) (450)
Accrued royalties (3,606) (3,218)
Deferred revenue (6,223) (3,142)
Net cash provided by operating activities 36,436 30,753
INVESTING ACTIVITIES:    
Business combinations, net of cash acquired (731) (21,449)
Proceeds from maturities of marketable securities 9,931 59,522
Purchases of marketable securities (5,223) (61,178)
Payments to acquire non-marketable equity investments 0 (1,257)
Payments to acquire equity method investments (1,750) 0
Payments associated with capitalized software development (16,577) (12,366)
Purchases of property and equipment (2,602) (1,734)
Net cash used in investing activities (16,952) (38,462)
FINANCING ACTIVITIES:    
Taxes paid related to net settlement of equity awards (471) (429)
Repurchases of common stock 0 (16,352)
Payment of cash dividends (19) (40)
Net cash used in financing activities (490) (16,821)
Effect of exchange rate changes on cash and cash equivalents (101) (1)
Net increase (decrease) in cash and cash equivalents 18,893 (24,531)
Cash and cash equivalents at beginning of period 36,566 131,538
Cash and cash equivalents at end of period 55,459 107,007
SUPPLEMENTAL CASH FLOW INFORMATION:    
Non-cash additions to non-marketable equity investments $ 0 $ 1,300